Trevi Therapeutics, Inc. TRVI Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance.
The official record: Trevi Therapeutics, Inc.’s 10-K, filed March 17, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent?
- Trevi Therapeutics, Inc. (TRVI) reported effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent of -20.9% in Q4 2025.
- How has Trevi Therapeutics, Inc.'s effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent changed year-over-year?
- Trevi Therapeutics, Inc.'s effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent increased by 3.2% year-over-year, from -21.6% to -20.9%.
- What does effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent mean?
- This metric represents the percentage impact of changes in the valuation allowance for deferred tax assets on the effective tax rate. It provides insight into how adjustments to tax asset recoverability expectations influence the company's reported tax position. This is critical for understanding the volatility of tax expenses in loss-making entities.